Literature DB >> 3440454

Epidemiology and prevention of Clostridium difficile infections in a leukemia unit.

M Delmée1, B Vandercam, V Avesani, J L Michaux.   

Abstract

A 29-month prospective study was carried out in a leukemia unit with the aim of investigating the epidemiology of Clostridium difficile infections and limiting their spread. Systematic cultures of stools and assays for cytotoxin were performed on patient admission and at weekly intervals, yielding 1,355 cultures and assays. The study period was divided in period A, before total unit renovation, and period B, afterwards. During period B all patient carriers of Clostridium difficile received vancomycin. A comparison of the two periods showed that the percentage of positive cultures fell from 16.6% to 3.6% and the positive toxin assays from 9.9% to 1.2%. It was concluded that colonization by Clostridium difficile can be prevented in hospital wards with generally high rates of infection by a combination of decontamination of the environment, introduction of preventive measures and treatment of Clostridium difficile carriage with vancomycin.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3440454     DOI: 10.1007/BF02013056

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  22 in total

1.  The epidemiology of Clostridium difficile with use of a typing scheme: nosocomial acquisition and cross-infection among immunocompromised patients.

Authors:  S R Heard; S O'Farrell; D Holland; S Crook; M J Barnett; S Tabaqchali
Journal:  J Infect Dis       Date:  1986-01       Impact factor: 5.226

2.  Epidemiology of colitis induced by Clostridium difficile in hamsters: application of a bacteriophage and bacteriocin typing system.

Authors:  C C Hawkins; B P Buggy; R Fekety; D R Schaberg
Journal:  J Infect Dis       Date:  1984-05       Impact factor: 5.226

3.  Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden, 1980-1982.

Authors:  B Aronsson; R Möllby; C E Nord
Journal:  J Infect Dis       Date:  1985-03       Impact factor: 5.226

4.  Clostridium difficile colitis associated with the use of antineoplastic agents.

Authors:  S D Miller; H J Koornhof
Journal:  Eur J Clin Microbiol       Date:  1984-02       Impact factor: 3.267

5.  Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia.

Authors:  J G Bartlett; T W Chang; M Gurwith; S L Gorbach; A B Onderdonk
Journal:  N Engl J Med       Date:  1978-03-09       Impact factor: 91.245

6.  Epidemiology of experimental enterocecitis due to Clostridium difficile.

Authors:  H E Larson; A B Price; S P Borriello
Journal:  J Infect Dis       Date:  1980-09       Impact factor: 5.226

7.  Nosocomial spread of Clostridium difficile.

Authors:  A M Savage; R H Alford
Journal:  Infect Control       Date:  1983 Jan-Feb

8.  Outbreaks of diarrhea associated with Clostridium difficile and its toxin in day-care centers: evidence of person-to-person spread.

Authors:  K Kim; H L DuPont; L K Pickering
Journal:  J Pediatr       Date:  1983-03       Impact factor: 4.406

9.  Application of a technique for serogrouping Clostridium difficile in an outbreak of antibiotic-associated diarrhoea.

Authors:  M Delmee; G Bulliard; G Simon
Journal:  J Infect       Date:  1986-07       Impact factor: 6.072

10.  Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis.

Authors:  K H Kim; R Fekety; D H Batts; D Brown; M Cudmore; J Silva; D Waters
Journal:  J Infect Dis       Date:  1981-01       Impact factor: 5.226

View more
  13 in total

1.  Evaluation of a new commercial Clostridium difficile toxin A enzyme immunoassay using diarrhoeal stools.

Authors:  M Delmée; T Mackey; A Hamitou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-03       Impact factor: 3.267

2.  Antimicrobial susceptibilities and serogroups of clinical strains of Clostridium difficile isolated in France in 1991 and 1997.

Authors:  F Barbut; D Decré; B Burghoffer; D Lesage; F Delisle; V Lalande; M Delmée; V Avesani; N Sano; C Coudert; J C Petit
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

3.  Characterization of flagella of Clostridium difficile and their role in serogrouping reactions.

Authors:  M Delmée; V Avesani; N Delferriere; G Burtonboy
Journal:  J Clin Microbiol       Date:  1990-10       Impact factor: 5.948

Review 4.  Management of adult Clostridium difficile digestive contaminations: a literature review.

Authors:  Fanny Mathias; Christophe Curti; Marc Montana; Charléric Bornet; Patrice Vanelle
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-11-29       Impact factor: 3.267

5.  Genotyping of outbreak-related and sporadic isolates of Clostridium difficile belonging to serogroup C.

Authors:  P van Dijck; V Avesani; M Delmée
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

6.  Relapse versus reinfection with Clostridium difficile.

Authors:  G L O'Neill; M H Beaman; T V Riley
Journal:  Epidemiol Infect       Date:  1991-12       Impact factor: 2.451

7.  Comparison of enterotoxin production, cytotoxin production, serogrouping, and antimicrobial susceptibilities of Clostridium difficile strains isolated from AIDS and human immunodeficiency virus-negative patients.

Authors:  F Barbut; C Depitre; M Delmée; G Corthier; J C Petit
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

8.  Influence of ceftriaxone on emergence of Clostridium difficile.

Authors:  T Lejko-Zupanc; J Zakelj; F Strle; M Janc; D Pleterski-Rigler
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

Review 9.  Epidemiological aspects of infections caused by Bacteroides fragilis and Clostridium difficile.

Authors:  S Tabaqchali; M Wilks
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-11       Impact factor: 3.267

10.  Prospective study of oral teicoplanin versus oral vancomycin for therapy of pseudomembranous colitis and Clostridium difficile-associated diarrhea.

Authors:  F de Lalla; R Nicolin; E Rinaldi; P Scarpellini; R Rigoli; V Manfrin; A Tramarin
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.